An Update on Pediatric Oncology and Hematology , An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Authors :
Max J. Coppes & Russell E. Ware & Jeffrey S. Dome
Date of Publication: 03/2010
This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and ...view more
This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP.
This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP.
Author Information
By Max J. Coppes, MD, PhD, MBA, Children's National Medical Center, Washington, DC; Russell E. Ware, MD, PhD, Director, Division of Hematology, Institute Co-Director, Cancer and Blood Diseases Institute, Associate Director, Global Health Center,Marjoy J. Johnson Chair of Hematology Translational Research, Cincinnati Children’s, Professor, UC Department of Pediatric,Cincinnati Ohio and Jeffrey S. Dome, MD, PhD
https://www.eu.elsevierhealth.com/an-update-on-pediatric-oncology-and-hematology-an-issue-of-hematologyoncology-clinics-of-north-america-9781437722024.html73199An Update on Pediatric Oncology and Hematology , An Issue of Hematology/Oncology Clinics of North Americahttps://www.eu.elsevierhealth.com/media/catalog/product/9/7/9781437722024_2.jpg61.4981.99EURInStock/Medicine and Surgery/Oncology/Nursing & Midwifery/Specialist Nursing/Books/Clinics Review Articles987898925255039561283717454982898915145120This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP. This issue highlights some of the exciting new developments in pediatric oncology and hematology. Three articles are devoted to pediatric leukemia, which remains the most common form of pediatric cancer. Specifically, articles address ALL, AML, and leukemia in patients with Down syndrome. Other articles that address pediatric oncology include CNS tumors and neuroblastoma as well as advances in cancer immunotherapy. A very interesting article addresses the challenges experienced by adults who survived a childhood cancer. The hematology articles in this issue cover aspects that most clinicians see on a regular basis—sickle cell disease, thalassemia, and hemophilia, and ITP.00add-to-cart97814377220242011 and earlierProfessionalBy Max J. Coppes, MD, PhD, MBA, Russell E. Ware, MD, PhD and Jeffrey S. Dome, MD, PhD20101Book152w x 229h (6.00" x 9.00")Saunders09 Mar 2010PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG>Max J. Coppes</STRONG>, MD, PhD, MBA, Children's National Medical Center, Washington, DC; <STRONG>Russell E. Ware</STRONG>, MD, PhD, Director, Division of Hematology, Institute Co-Director, Cancer and Blood Diseases Institute, Associate Director, Global Health Center,Marjoy J. Johnson Chair of Hematology Translational Research, Cincinnati Children’s, Professor, UC Department of Pediatric,Cincinnati Ohio and <STRONG>Jeffrey S. Dome</STRONG>, MD, PhDClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
